13-25372298-G-A

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6

The NM_016529.6(ATP8A2):​c.76+10G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00125 in 1,464,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 0 hom. )

Consequence

ATP8A2
NM_016529.6 intron

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 0.269
Variant links:
Genes affected
ATP8A2 (HGNC:13533): (ATPase phospholipid transporting 8A2) The protein encoded by this gene is a member of the P4 ATPase family of proteins, which are thought to be involved in a process called lipid flipping, whereby phospholipids are translocated inwards from the exoplasmic leaflet to the cytosolic leaflet of the cell membrane, which aids in generating and maintaining asymmetry in membrane lipids. This protein is predicted to contain an E1 E2 ATPase, a haloacid dehalogenase-like hydrolase (HAD) domain, and multiple transmembrane domains. Associations between this protein and cell cycle control protein 50A are important for translocation of phosphatidylserine across membranes. Mutations in this gene have been associated with a syndrome (CAMRQ4) characterized by cerebellar ataxia and cognitive disabilities. In addition, a translocation breakpoint within this gene was observed in an individual with neurological dysfunction. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 13-25372298-G-A is Benign according to our data. Variant chr13-25372298-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 446062.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Uncertain_significance=1}. Variant chr13-25372298-G-A is described in Lovd as [Likely_benign].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ATP8A2NM_016529.6 linkuse as main transcriptc.76+10G>A intron_variant ENST00000381655.7 NP_057613.4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ATP8A2ENST00000381655.7 linkuse as main transcriptc.76+10G>A intron_variant 1 NM_016529.6 ENSP00000371070 Q9NTI2-4

Frequencies

GnomAD3 genomes
AF:
0.00101
AC:
154
AN:
151778
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00837
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000192
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00112
Gnomad OTH
AF:
0.000960
GnomAD3 exomes
AF:
0.00117
AC:
105
AN:
89790
Hom.:
0
AF XY:
0.00117
AC XY:
59
AN XY:
50576
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000749
Gnomad ASJ exome
AF:
0.00769
Gnomad EAS exome
AF:
0.000370
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00115
Gnomad OTH exome
AF:
0.00258
GnomAD4 exome
AF:
0.00127
AC:
1671
AN:
1313054
Hom.:
0
Cov.:
31
AF XY:
0.00131
AC XY:
848
AN XY:
647602
show subpopulations
Gnomad4 AFR exome
AF:
0.000615
Gnomad4 AMR exome
AF:
0.000784
Gnomad4 ASJ exome
AF:
0.00810
Gnomad4 EAS exome
AF:
0.0000370
Gnomad4 SAS exome
AF:
0.0000138
Gnomad4 FIN exome
AF:
0.0000432
Gnomad4 NFE exome
AF:
0.00132
Gnomad4 OTH exome
AF:
0.00139
GnomAD4 genome
AF:
0.00101
AC:
154
AN:
151778
Hom.:
0
Cov.:
32
AF XY:
0.000971
AC XY:
72
AN XY:
74146
show subpopulations
Gnomad4 AFR
AF:
0.000652
Gnomad4 AMR
AF:
0.00118
Gnomad4 ASJ
AF:
0.00837
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000192
Gnomad4 NFE
AF:
0.00112
Gnomad4 OTH
AF:
0.000960
Bravo
AF:
0.00102

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 28, 2024- -
Uncertain significance, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJun 26, 2017- -
ATP8A2-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 28, 2019This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
16
DANN
Benign
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs369291641; hg19: chr13-25946436; API